Reuters logo
BRIEF-Vital Therapies announces characteristics of early subjects in VTL-308 pivotal study
June 5, 2017 / 12:31 PM / 5 months ago

BRIEF-Vital Therapies announces characteristics of early subjects in VTL-308 pivotal study

June 5 (Reuters) - Vital Therapies Inc

* Announces characteristics of early subjects in VTL-308 pivotal study of ELAD system in severe alcoholic hepatitis

* Determined from VTI-208 that younger would comprise population most likely to exhibit improved survival in prospectively designed VTL-308 clinical trial​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below